Conclusion The discussion surrounding GLP-1 medicines illustrates that the real legacy of COVID-19 is not simply the reaffirmation of the TRIPS flexibilities
Designed to manage type 2 diabetes by regulating blood sugar, slowing digestion and reducing appetite, GLP-1s are now taken by millions of people across the world for weight loss, with Australian prescriptions increasing almost 10-fold since 2020 and use in the US more than quadrupling
It has a cushiony, cloud-like feel without being too much like quicksand
If you know upfront that indefinite treatment is not financially or personally viable, that knowledge should shape your initial goals and your investment in building lifestyle habits during the treatment window
The clinical significance of this improvement becomes clearer when translated to real world outcomes
Cao CF, Ma KL, Li QL, et al